Description

▪ Introduction

Primo Med by Pharma Nevis is a pharmaceutical-grade injectable solution delivering 100 mg/mL of Methenolone Enanthate, formulated for use in laboratory and analytical research applications. Recognized for its mild androgenic and sustained anabolic properties, Methenolone Enanthate is widely studied in controlled environments focused on muscle tissue preservation, nitrogen balance, and protein synthesis pathways under catabolic stress conditions.

Its low aromatization and favorable anabolic profile make it a consistent choice for long-duration study models requiring minimal hormonal fluctuation.

▪ Product Details

• Active Ingredient: Methenolone Enanthate

• Dosage Strength: 100 mg/mL

• Form: Injectable solution (intramuscular)

• Brand: Pharma Nevis

• Package Size: 10 mL multi-dose vial

• Intended Use: Laboratory and analytical use only

▪ Pharmacokinetics

Methenolone Enanthate exhibits a half-life of approximately 10–14 days, providing extended compound release with infrequent dosing. It demonstrates minimal estrogenic conversion and supports sustained anabolic activity across long-term observational protocols. This makes it ideal for pharmacokinetic models investigating muscle retention and metabolic support under nutrient-deficient conditions.

▪ Usage Recommendations

• Route: Intramuscular injection using aseptic technique

• Suggested Research Dosing: To be determined based on institutional protocol

• Handling Notes: Store in a sterile, temperature-controlled environment

• Use Statement: For laboratory and analytical use only by qualified personnel

▪ Disclaimer

This product is strictly intended for laboratory research and analytical use. It is not approved for human consumption or medical application. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical conditions. All handling must follow institutional safety protocols and local regulations.